Article

Risk Factors for Malignancy in Indeterminate Thyroid Nodules

Since roughly 70-80% of indeterminate thyroid nodules are diagnosed as benign from histologic follow-up of fine-needle aspiration cytology, researchers have conducted numerous studies to identify the clinical risk factors that predict malignancy.

Since roughly 70-80% of indeterminate thyroid nodules (ITN) are diagnosed as benign from histologic follow-up of fine-needle aspiration cytology (FNAC), researchers have conducted numerous studies to identify the clinical risk factors that predict malignancy.

For their review of 19 such studies published through December 2012, a team of European scientists examined data on 3,494 patients who underwent FNAC that indicated ITN.

Within the pooled patient population, the prevalence of malignant nodules was 28%, though it was 26% among females and 34% among males. Thus, men appeared to have a higher risk of malignant ITN, but unlike patient gender, the researchers were unable to determine a possible link between patient age and malignancy because age-related demographics were unavailable.

Nodule size was also difficult to analyze, due to the differing reporting methods employed in the data sources. Experts have disagreed on the efficacy of nodule size as a malignancy parameter, and the conflicting results among the individual studies included in the meta-analysis failed to clarify the controversy.

Nevertheless, the authors concluded that male patients who have nodules >4 cm in diameter “should be considered at higher risk of cancer.”

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.